共 50 条
Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung
被引:8
|作者:
Mejia, Javier Del Aguila
[1
]
Armon, Subasri
[1
]
Campbell, Fiona
[2
]
Colling, Richard
[3
]
Chechlinska, Magdalena
[4
]
Kowalewska, Magdalena
[4
]
Pollan, Marina
[5
,6
]
Holdenrieder, Stefan
[7
]
Tan, Puay Hoon
[8
]
Cree, Ian
[1
]
Ruiz, Blanca Iciar Indave
[1
]
机构:
[1] Int Agcy Res Canc, WHO IARC Classificat Tumours Programme, Lyon, France
[2] Newcastle Univ, Evidence Synth Grp, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[3] Oxford Univ Hosp NHS Fdn Trust, Dept Cellular Pathol, Oxford, England
[4] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Canc Biol, Warsaw, Poland
[5] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain
[6] CIBERESP, Madrid, Spain
[7] Deutsch Herzzentrum Munich, Munich Biomarker Res Ctr, Inst Lab Med, Munich, Germany
[8] Singapore Gen Hosp, Div Pathol, Singapore, Singapore
来源:
关键词:
PATHOLOGY;
ONCOLOGY;
Respiratory tract tumours;
D O I:
10.1136/bmjopen-2022-061240
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction There are gaps in the evidence base of tumour classification despite being essential for cancer diagnosis, treatment and patient care. The WHO in charge of the production of an updated international classification, the WHO Classification of Tumours (WCT), aims to adapt evidence gap map (EGM) methodology to inform future editions of the WCT, by providing a visual summary of the existing evidence. Methods and analysis Bibliographical references used in the WCT fifth edition of Tumours of the Lung (Thoracic Tumours volume) will be used as search results of a literature search. A descriptive analysis of the cited evidence for tumour types and descriptors will be drafted and plotted in EPPI-Reviewer to develop a visual evidence map. The resulting EGM will reflect the number of cited studies in the size of the spheres, and the level of evidence by applying a four-colour code (red=low level evidence, orange=moderate level, green=high level and blue=unclassifiable). Overview of the findings will be provided in narrative form and a report will discuss the overall stage of cited research in the WCT and will include analysis of gaps, under-researched categories of tumour descriptors and pockets of low-level evidence. Ethics and dissemination No ethics approval will be required as this is a study of previously published material. Findings of the EGM will be published and used to guide editors, stakeholders and researchers for future research planning and related decision-making, especially for the development of future editions of the WCT. PROSPERO registration number CRD42022302327.
引用
收藏
页数:6
相关论文